InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
T+90 hit rate
100%
T+90 mean return
+37.2%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Deardorf Caren, Directeur Commercial. Officer active across 2 companies, notably Magenta Therapeutics, Inc.. Cumulatively, 9 disclosures have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €71k. History available since 14 September 2021. The latest transaction was disclosed on 7 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
5,925 sharesCommon StockSEC:0001628280-26-044721:0
3,400 shares0Common StockSEC:0000950170-24-071931:0
6,000 shares0Common StockSEC:0001209191-23-038823:0
3,000 shares@ US$0.943.6% of flowCommon StockSEC:0000899243-22-037432:0
3,000 shares@ US$0.993.7% of flowCommon StockSEC:0000899243-22-021185:0
6,238 shares@ US$6.7348.1% of flowCommon StockSEC:0000899243-21-036600:0
6,238 shares@ US$6.7346.4% of flowCommon StockSEC:0000899243-21-036600
20,000 shares0Common StockSEC:0000899243-21-036338:0
20,000 shares0Common StockSEC:0000899243-21-036338
9 of 9 declarations
About Deardorf Caren
Caren Deardorf is the Chief Commercial Officer at Magenta Therapeutics, Inc. She is responsible for the company's commercial strategy and revenue growth. With extensive experience in the industry, she leads business development initiatives and strategic partnerships. Her role is crucial in positioning Magenta Therapeutics as a leader in its field, ensuring alignment between business objectives and market needs.
